Actinium Announces Voting Results from Its Annual Shareholder Meeting

Results Indicate Strong Support for Board of Directors and Company Proposals NEW YORK -- -- Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced the voting results from its annual general meeting of the Company's shareholders which ... (more)

http://www.hispanicbusiness.com/2013/12/30/actinium_announces_voting_results_from_its.htm